- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Bepridil is a cardiovascular drug used to treat angina, a type of chest pain caused by reduced blood flow to the heart. It is a calcium channel blocker, meaning it works by blocking the flow of calcium into the cells of the heart and blood vessels, which helps to reduce the force of heart contractions and relax the blood vessels. Bepridil is available in both oral and intravenous forms, and is typically used in combination with other medications.
Bepridil is a relatively uncommon drug, and is not widely used in the United States. It is more commonly used in Europe, where it is approved for use in some countries. It is also used in some parts of Asia and Africa.
The market for Bepridil is relatively small, and is dominated by a few major pharmaceutical companies. Some of the companies in the market include Pfizer, Merck, Sanofi, and Novartis. Show Less Read more